Key Events This Week
20 Jul: Stock opens strong at Rs.1,560.55 (+1.73%) amid stable market conditions
22 Jul: Sharp open interest surge in derivatives despite 3.01% price decline
24 Jul: Technical momentum shifts to mildly bullish with mixed indicator signals
24 Jul: Week closes at Rs.1,531.50 (-0.17%) outperforming Sensex decline

Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals
2026-07-24 08:00:29Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a modest day decline of 0.59%, the stock’s technical indicators present a complex picture, with some signals suggesting sustained strength while others hint at caution. This nuanced technical landscape warrants close attention from investors seeking to navigate the stock’s evolving trend dynamics.
Read full news article
Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals
2026-07-22 15:00:09Aurobindo Pharma Ltd. has witnessed a notable 13.6% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of volume patterns and price movements that investors must carefully analyse.
Read full news article
Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Price Action
2026-07-22 14:00:09Aurobindo Pharma Ltd. has witnessed a notable 13.4% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price movements, suggests evolving market positioning and potential directional bets among traders.
Read full news article
Aurobindo Pharma Sees Significant Open Interest Surge Amid Mixed Price Action
2026-07-22 13:00:08Aurobindo Pharma Ltd. has witnessed a notable 10.9% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a 2.94% decline in the stock price on 22 Jul 2026, the surge in open interest and volume patterns suggest evolving directional bets amid broader sector and market pressures.
Read full news article
Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Price Action
2026-07-22 12:00:08Aurobindo Pharma Ltd. has witnessed a notable 10.46% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price movements, offers insights into evolving market positioning and potential directional bets by investors in the pharmaceuticals and biotechnology sector.
Read full news article
Aurobindo Pharma Ltd. is Rated Hold
2026-07-22 10:11:01Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article






